Agoracom: Small Cap Investment - Chitogenx Inc. - Ortho Regenerative Technologies: Interim Financial Statements

Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Reply New Message

Back To Forum List View

AGORACOM-AB

Rank: Administrator [?]

Points: 500742 [?]

Votes: 0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Ortho Regenerative Technologies: Interim Financial Statements

posted on Jun 29, 2021 04:29PM

SEDAR Interim Financial Statements

Ortho Regenerative Technologies Inc (C:ORTH)
Shares Issued 34,872,899
Last Close 6/29/2021 $0.32
Tuesday June 29 2021 - SEDAR Interim Financial Statements